I agree that this site is using cookies. You can find further informations here.
X
Scheen, André
926  results:
Search for persons X
?
1

Paradoxical real-life underuse of GLP-1 receptor agonists i..:

Scheen, André J.
Diabetes Epidemiology and Management.  14 (2024)  - p. 100197 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Real-life underuse of SGLT2 inhibitors for patients with ty..:

Scheen, André J.
Diabetes Epidemiology and Management.  13 (2024)  - p. 100184 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Cardiovascular protection significantly depends on HbA1c im..:

Scheen, André J.
Diabetes & Metabolism.  50 (2024)  2 - p. 101508 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Similar incidence of stroke with SGLT2 inhibitors and GLP-1..:

Scheen, André J.
Diabetes Epidemiology and Management.  13 (2024)  - p. 100179 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and safety profile of SGLT2 inhibitors in the elde..:

Scheen, André J. ; Bonnet, Fabrice
Diabetes & Metabolism.  49 (2023)  2 - p. 101419 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Metabolic disorders induced by psychotropic drugs:

Scheen, André J.
Annales d'Endocrinologie.  84 (2023)  3 - p. 357-363 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Clinical pharmacology of antidiabetic drugs: What can be ex..:

Scheen, André J.
La Presse Médicale.  52 (2023)  1 - p. 104158 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Use of SGLT2 inhibitors after bariatric/metabolic surgery: ..:

Scheen, André J.
Diabetes & Metabolism.  49 (2023)  4 - p. 101453 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Comparative effects between old and new antidiabetic agents..:

Scheen, André J.
Diabetes Epidemiology and Management.  11 (2023)  - p. 100145 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Dual GIP/GLP-1 receptor agonists: New advances for treating..:

Scheen, André J.
Annales d'Endocrinologie.  84 (2023)  2 - p. 316-321 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Metformin, Sulfonylureas, DPP-4 Inhibitors and Cardiovascul..:

, In: Diabetes and Cardiovascular Disease; Contemporary Cardiology,
Scheen, André J. - p. 895-921 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Cardiovascular and renal outcomes with SGLT2 inhibitors: Re..:

Scheen, André J.
Diabetes Epidemiology and Management.  10 (2023)  - p. 100135 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Underuse of glucose-lowering medications associated with ca..:

Scheen, André J.
The Lancet Regional Health - Europe.  29 (2023)  - p. 100627 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Do SGLT2 inhibitors and GLP-1 receptor agonists modulate di..:

Scheen, André J.
Diabetes & Metabolism.  49 (2023)  5 - p. 101474 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Lower-limb amputations in patients treated with SGLT2 inhib..:

Scheen, Andre J.
Diabetes Epidemiology and Management.  6 (2022)  - p. 100054 , 2022
Link: https://doi.org/10.1016/..
 
1-15